Quick answers
- What is Uptravi?
- Uptravi is a brand name of Selexipag, a prescription medicine. The FDA NDC Directory lists 11 Uptravi products in 11 strengths and forms.
- Who makes Uptravi?
- Actelion holds the FDA application for Uptravi (NDA207947, approved December 21, 2015).
- Is there a generic or store brand of Uptravi?
- Other products of Selexipag are listed with the FDA, but none in exactly the same strength and form as a Uptravi product.
- Has Uptravi been recalled?
- No recall linked to Uptravi products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Uptravi is
Each Uptravi product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Selexipag · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| selexipag 100 ug tablet, film coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 1000 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 1200 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 1400 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 150 ug tablet, film coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 1600 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 1800 ug/10 mL injection, powder, for solution (intravenous) | Uptravi | None listed | DailyMed |
| selexipag 200 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 400 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 600 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
| selexipag 800 ug tablet, coated (oral) | Uptravi | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Selexipag →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Uptravi
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Uptravi products.
- Actelion Pharmaceuticals US, Inc.11 products
Recalls
No recall linked to Uptravi products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.